CSPAN3 Forum On Pharmaceutical Development And Drug Costs November 25, 2015
Hepatitis c, diabetes and oncology are the primary drivers of the spending growth. Prescription growth is 1. 2 for the year. That is a substantial reduction from last year. The primary effect is the rescheduling of hydrocodone to more restrictive schedule which cut that market by 30 . And also you have more chronic care prescriptions are 90day prescriptions. 75 is on specialists. You cant look at that market here or everywhere around the World Without talking specialty. And next year we expect crestor to go off. So these are whats driving spending growth. You can see hepatitis at the top follo...
Source: archive.org
